IRIS
CHISARI, CLARA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.338
AS - Asia 3.304
EU - Europa 2.957
SA - Sud America 526
AF - Africa 515
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 12.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.165
SG - Singapore 1.644
RU - Federazione Russa 1.177
CN - Cina 848
IT - Italia 769
BR - Brasile 445
IE - Irlanda 339
CI - Costa d'Avorio 292
VN - Vietnam 268
KR - Corea 170
FR - Francia 145
UA - Ucraina 123
CA - Canada 114
BD - Bangladesh 85
DE - Germania 83
GB - Regno Unito 83
IN - India 70
NG - Nigeria 64
SN - Senegal 63
NL - Olanda 46
FI - Finlandia 38
SE - Svezia 37
MX - Messico 36
ZA - Sudafrica 34
TR - Turchia 32
PL - Polonia 30
IQ - Iraq 25
AR - Argentina 23
HK - Hong Kong 23
JP - Giappone 22
BJ - Benin 21
ES - Italia 18
UZ - Uzbekistan 17
VE - Venezuela 17
CH - Svizzera 16
PK - Pakistan 16
EC - Ecuador 13
AE - Emirati Arabi Uniti 11
ID - Indonesia 11
EG - Egitto 9
KE - Kenya 9
AT - Austria 8
CL - Cile 8
MA - Marocco 7
SA - Arabia Saudita 7
CO - Colombia 6
CZ - Repubblica Ceca 6
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
PE - Perù 6
PY - Paraguay 6
TN - Tunisia 6
BG - Bulgaria 5
HR - Croazia 5
IR - Iran 5
LT - Lituania 5
TH - Thailandia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
JM - Giamaica 4
AU - Australia 3
ET - Etiopia 3
LV - Lettonia 3
PH - Filippine 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
BE - Belgio 2
DM - Dominica 2
EU - Europa 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
NI - Nicaragua 1
Totale 12.641
Salva come PNG Salva come JPEG
Città #
Singapore 1.008
Dallas 947
Santa Clara 693
Moscow 516
San Jose 447
Chandler 445
Dublin 331
Ashburn 326
Abidjan 291
Hefei 256
Chicago 232
Catania 169
Seoul 168
Los Angeles 142
Boardman 138
Beijing 111
Lauterbourg 108
Jacksonville 107
Council Bluffs 94
Civitanova Marche 90
Cambridge 80
Lawrence 79
Andover 76
Ho Chi Minh City 75
New York 68
Dakar 63
Nanjing 60
Saint Petersburg 60
Hanoi 55
Toronto 55
São Paulo 52
Des Moines 48
Buffalo 46
Lagos 33
Bremen 32
Milan 31
Orem 29
Rome 28
Houston 27
Abuja 26
Dong Ket 26
Denver 25
Warsaw 25
San Francisco 24
Wilmington 24
Johannesburg 23
Lappeenranta 23
Amsterdam 22
Hong Kong 22
Montreal 22
Cotonou 21
Tokyo 20
London 18
Columbus 17
Nanchang 17
Phoenix 17
Shenyang 17
Stockholm 16
The Dalles 16
Chennai 15
Mexico City 15
Naples 15
Palermo 15
Rio de Janeiro 15
Belo Horizonte 14
Brooklyn 14
Seattle 14
Da Nang 13
Hebei 13
Poplar 13
Manchester 12
Mascalucia 12
Munich 12
Ottawa 11
Redwood City 11
Ankara 10
Bernareggio 10
Charlotte 10
Florence 10
Haiphong 10
Helsinki 10
Kiev 10
Mumbai 10
San Mateo 10
Abu Dhabi 9
Atlanta 9
Baghdad 9
Frankfurt am Main 9
Tashkent 9
Boston 8
Brasília 8
Giarre 8
Istanbul 8
Porcari 8
Porto Alegre 8
Rende 8
Cape Town 7
Changsha 7
Nairobi 7
Pune 7
Totale 8.470
Salva come PNG Salva come JPEG
Nome #
The ocular ecosystem in the discoid lupus erythematosus 232
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease 184
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 176
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 175
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 170
Amyotrophic lateral sclerosis: differential diagnosis with cervical myeloradiculopathy 168
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 164
Aging eye microbiota in dry eye syndrome in patients treated with enterococcus faecium and saccharomyces boulardii 163
An update on the safety of treating relapsing-remitting multiple sclerosis 152
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 151
Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach 150
An update on the pharmacological management of pain in patients with multiple sclerosis 146
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 140
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 139
Microbiological Etiology of Chronic skin lesions in type 2 Diabetic Subjects 139
Amniotic membrane use in type 2 diabetes patients with chronic ulcers: Microbiological evaluation and therapeutic benefits 138
Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report 137
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 135
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights 134
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 132
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 130
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 129
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 129
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 127
Functional Neurological disorders; those bizarre and painfull disconnections between brain and body 126
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 126
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 125
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 123
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 122
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach 122
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 118
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 116
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 115
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 115
The Italian Multiple Sclerosis Register Experience With Cladribine 114
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 114
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 113
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 112
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease 112
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 112
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 112
Etiology of chronic skin lesions in subjects with peripheral arterial disease 112
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 111
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 110
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 109
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 108
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 107
Palliative care in multiple sclerosis 107
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 107
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis 105
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis 105
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 105
Pharmacoeconomics of synthetic therapies for multiple sclerosis 105
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 104
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 104
Valutazione dell’efficacia clinica-batteriologica dell’ofloxacina e della levofloxacina nelle congiuntiviti batteriche 104
Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease 104
Abnormal Eye Movements due to Disease of the Extraocular Muscles and Their Innervation 103
Optic Nerve Head and Retinal Changes in Idiopathic Intracranial Hypertension: Correlation with Short-Term Cerebrospinal Fluid Pressure Monitoring 102
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 102
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 100
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 100
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 99
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 96
Risk factors for ocular surface disorders in patients with type 2 diabetes 95
A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols 95
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients 94
A MACROSCALE MODELLING APPROACH FOR NONLINEAR ANALYSIS OF MASONRY ARCH BRIDGES 93
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 93
Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. 91
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 91
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis 91
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager®evaluation study 90
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements 89
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 89
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study) 88
Incidence of late onset multiple sclerosis in Italy: a population-based study 88
The ocular surface in patients video display terminal (VDT) 88
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 88
The effects of blood glucose regulation onn the microbiota ocular in Type II diabetic subjects 87
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 87
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 87
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 86
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 83
WII may improve physical abilities in multiple sclerosis: a randomized single blind study 83
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 83
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis 82
The efficacy of natalizumab and fingolimod on cognition in relapsing-remitting multiple sclerosis patients 82
The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface 80
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial 80
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study 80
Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome 79
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 79
Rituximab for the treatment of multiple sclerosis: a review 78
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 77
Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily 77
New strategies to manage the safety of cladribine in patients with multiple sclerosis 76
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study 76
Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study 75
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis 75
Totale 11.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022595 54 93 13 22 90 4 88 18 18 4 19 172
2022/20231.281 87 90 29 138 100 196 16 269 282 12 50 12
2023/2024708 34 155 41 32 27 159 11 56 8 12 109 64
2024/20252.725 61 376 137 148 499 399 120 60 222 270 219 214
2025/20266.649 393 590 983 438 984 1.273 638 191 284 367 246 262
Totale 12.874